Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for January 30th

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 30th:

Artisan Partners Asset Management Inc. (APAM - Free Report) : This investment manager has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 7.7%, compared with the industry average of 2.2%. Its five-year average dividend yield is 7.6%.

Capital Southwest Corporation CSWC: This business development company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 7.5%, compared with the industry average of 2.2%. Its five-year average dividend yield is 4.2%.

Janus Henderson Group plc JHG: This asset management holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 5.6%, compared with the industry average of 2.2%. Its five-year average dividend yield is 3.9%.

Banco Macro S.A. BMA: This provider of various banking products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.9% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 7.1%, compared with the industry average of 3.5%. Its five-year average dividend yield is 3.2%.

Macro Bank Inc. Dividend Yield (TTM)

Macro Bank Inc. Dividend Yield (TTM)

Macro Bank Inc. dividend-yield-ttm | Macro Bank Inc. Quote

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Artisan Partners Asset Management Inc. (APAM) - free report >>